AzTrials
AzTrials

Frail ElderlyFRAIL-ALAMANCT07572851

Functional Changes and Fall Risk in Older Adults Participating in a Frailty Program

An observational study of Frail Elderly and Fall Risk, run by University of Vigo at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective observational study aims to describe changes in physical function and fall risk in adults aged 70 years and older participating in a routine multicomponent frailty and falls prevention program in primary care. Read more about this study

Who is it for?
Ages 70 years and older
Conditions the study is for
Frail Elderly, Fall Risk
What is being tested?
Multicomponent Exercise Program- 1 times per week. and Multicomponent Exercise Program- 2 times per week.
How many people
56 participants
Where
1 siteSpain
Study dates
2 Apr 2026to 1 Jun 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: The study population consists of older adults aged 70 years and above who are currently enrolled in the frailty prevention program within the Galician public health system. These individuals have been identified as frail or pre-frail through routine primary care screening and demonstrate sufficient functional capacity, as indicated by a Barthel Index score of 90 or higher, reflecting independence in basic activities of daily living. Eligible participants must be able to understand the study procedures and provide informed consent, ensuring that they can engage safely and meaningfully in the intervention. All participants are actively involved in the structured frailty program delivered by primary care physiotherapy services, which focuses on preventing functional decline and reducing the risk of falls. Individuals will be excluded if they present with any medical contraindication to exercise.

Who may be able to join

  • Age ≥70 years
  • Barthel Index ≥90
  • Participation in the frailty program
  • Ability to provide informed consent

Who cannot join

  • Medical contraindication to exercise

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • A Lama

    A Lama, Pontevedra, 36830

Other trials in Spain

About this study

Official title: Observational Study of Functional Changes and Fall Risk in Older Adults Participating in a Multicomponent Frailty and Falls Prevention Program in Primary Care

This prospective observational study aims to describe changes in physical function and fall risk in adults aged 70 years and older participating in a routine multicomponent frailty and falls prevention program in primary care. Participants are evaluated before and after the intervention, and additional postural control variables are recorded using a pressure platform without modifying routine clinical care.

Read the detailed description

Frailty is a clinical condition associated with increased vulnerability to adverse health outcomes, including falls, disability, and mortality. In the Galician public health system, a structured frailty and falls prevention program is implemented within primary care physiotherapy services.

This study is designed as a prospective, longitudinal observational study with pre-post evaluation under real-world clinical conditions, without modifying clinical decision-making or healthcare organization.

Participants aged 70 years and older enrolled in the routine program undergo baseline (T0) and post-intervention (T1) assessments after 8 weeks. The intervention consists of a multicomponent exercise program including strength, balance, and functional training.

The primary objective is to describe changes in physical function and fall risk. Secondary objectives include the characterization of participants, analysis of adherence, recording of adverse events, and evaluation of the feasibility and utility of pressure-platform-based balance assessment.

Additional functional variables (muscle strength, aerobic capacity, and clinical balance tests) are included as part of the standardized functional assessment protocol implemented in routine care.

Being tested
Multicomponent Exercise Program- 1 times per week., Multicomponent Exercise Program- 2 times per week.
Keywords
Frailty, Falls prevention, Older adults, Physical function, SPPB, Sit-to-Stand, Primary care physiotherapy
Medical subject headings
Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multicomponent Exercise Program- 1 times per week.Other

    Group-based therapeutic exercise program lasting 8 weeks, including strength, functional, and aerobic training, delivered 1 times per week.

  • Multicomponent Exercise Program- 2 times per week.Other

    Group-based therapeutic exercise program lasting 8 weeks, including strength, functional, and aerobic training, delivered 2 times per week.

Study groups in NCT07572851
Study groupRoleWhat they receive
Frailty Program Participants- 1 day/week exercise programAdults aged ≥70 years with preserved basic functional independence (Barthel Index ≥90) participating in a routine multicomponent exercise program for frailty and fall prevention in primary care. The participants of this group will attend one multicomponent exercise session per week
Receives: Other: Multicomponent Exercise Program- 1 times per week.
Frailty Program Participants- 2 day/week exercise programAdults aged ≥70 years with preserved basic functional independence (Barthel Index ≥90) participating in a routine multicomponent exercise program for frailty and fall prevention in primary care. The participants of this group will attend two multicomponent exercise session per week
Receives: Other: Multicomponent Exercise Program- 2 times per week.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Physical Performance Short Physical Performance Battery (SPPB)

    Change in Short Physical Performance Battery (SPPB) total score. The SPPB is a composite measure of lower extremity function including balance, gait speed, and chair stand tests.

    • Score range: 0 to 12
    • Interpretation: Higher scores indicate better physical performance
    • Unit of measure: Points on a scale

    Measured: Baseline (T0) and post-intervention (8-12 weeks)

  2. Change in Fall Risk

    Change in fall risk indicators based on clinical assessment (falls history and gait impairment).

    Minimum value: 0 Maximum value: Not applicable (composite clinical indicator; upper bound not fixed) Interpretation: Higher values indicate worse outcome (greater fall risk)

    Measured: Baseline (T0) and post-intervention (8-12 weeks)

  3. Change in Instrumented Balance: Center of Pressure (CoP) Sway Area

    -Change in Center of Pressure (CoP) Sway Area

    Change in postural sway area measured using a pressure platform. The Center of Pressure (CoP) sway area represents the area covered by the CoP trajectory during quiet standing.

    Unit of measure: square millimeters (mm²). Higher values indicate worse postural stability.

    Minimum value: 0 mm² Maximum value: Not applicable (no fixed upper limit) Interpretation: Higher values indicate worse postural stability

    Measured: Baseline (T0) and post-intervention (8-12 weeks)

  4. Change in Instrumented Balance: Center of Pressure (CoP) Velocity

    Change in Center of Pressure (CoP) Velocity Change in mean velocity of center of pressure displacement.

    • Unit of measure: mm/s

    Minimum value: 0 mm/s Maximum value: Not applicable (no fixed upper limit) Interpretation: Higher values indicate worse postural stability

    Measured: Baseline (T0) and post-intervention (8-12 weeks)

  5. Change in Instrumented Balance:Center of Pressure (CoP) Path Length.

    Change in Center of Pressure (CoP) Path Length Change in total trajectory length of center of pressure.

    • Unit of measure: mm

    Minimum value: 0 mm Maximum value: Not applicable (no fixed upper limit) Interpretation: Higher values indicate worse postural stability

    Measured: Baseline (T0) and post-intervention (8-12 weeks)

Secondary outcomes (7)
  1. Functional Performance: Change in Timed Up and Go (TUG) Test

    Time required to stand up, walk 3 meters, turn, return, and sit down.

    • Unit of measure: Seconds
    • Interpretation: Lower values indicate better performance

    The interpretation of TUG results depends on the population (healthy adults, older adults, clinical populations), but general reference thresholds are as follows:

    • Older Adults (Community-Dwelling) < 12 seconds: Normal functional mobility 12-20 seconds: Mild impairment / increased risk of functional decline > 20 seconds: Significant mobility impairment
    • Fall Risk Interpretation > 13.5 seconds: Increased risk of falls (commonly used cut-off)

    Clinical Populations (frail patients) 20-30 seconds: Moderate functional limitation > 30 seconds: Severe dependency in mobility

    A change of approximately ≥ 2-3 seconds is often considered clinically meaningful, depending on the population studied.

    Measured: Baseline (T0) and post-intervention (8-12 weeks)

  2. Functional Performance: Change in Gait Speed (4-Meter Walk Test)

    Change in usual walking speed assessed over a 4-meter distance. Gait speed is calculated as distance divided by time and expressed in meters per second (m/s).

    Only gait speed is reported as the outcome measure. Unit of measure: meters per second (m/s). Higher values indicate better functional performance.

    Minimum value: 0 m/s Maximum value: Not applicable (no fixed upper limit; typically < 2.5 m/s in adults) Interpretation: Higher values indicate better functional performance

    Measured: Baseline (T0) and post-intervention (8-12 weeks)

  3. Functional Performance: Change in FRAIL Scale Score

    Assessment of frailty status using the FRAIL scale.

    • Score range: 0 to 5
    • Interpretation: Higher scores indicate greater frailty
    • Unit of measure: Points on a scale

    Measured: Baseline (T0) and post-intervention (8-12 weeks)

  4. Muscle Strength: Change in Handgrip Strength

    Assessment of maximal isometric grip strength using a dynamometer.

    • Unit of measure: kg (or Newtons, depending on device)
    • Interpretation: Higher values indicate greater strength

    Measured: Baseline (T0) and post-intervention (8-12 weeks)

  5. Muscle Strength: Change in 30-Second Sit-to-Stand Test

    • Unit of measure: Repetitions
    • Interpretation: Higher values indicate better lower limb strength

    Measured: Baseline (T0) and post-intervention (8-12 weeks)

  6. Balance

    Unipodal stance or Functional Reach Test

    Measured: Baseline (T0) and post-intervention (8-12 weeks)

  7. Aerobic Capacity

    2-Minute Step Test

    Measured: Baseline (T0) and post-intervention (8-12 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 May 2026
  2. Study start2 Apr 2026
  3. Primary completion1 Jun 2026
  4. Study completion1 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
56 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07572851
Sponsor's protocol ID
025/447
Acronym
FRAIL-ALAMA
Status last verified
Sep 2026
First submitted
2 Apr 2026
Last updated
23 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Protocol states data will not be shared with third parties

Publications

  • Fragala MS, Cadore EL, Dorgo S, Izquierdo M, Kraemer WJ, Peterson MD, Ryan ED. Resistance Training for Older Adults: Position Statement From the National Strength and Conditioning Association. J Strength Cond Res. 2019 Aug;33(8):2019-2052. doi: 10.1519/JSC.0000000000003230.

    PubMed 31343601
  • Beckwee D, Delaere A, Aelbrecht S, Baert V, Beaudart C, Bruyere O, de Saint-Hubert M, Bautmans I. Exercise Interventions for the Prevention and Treatment of Sarcopenia. A Systematic Umbrella Review. J Nutr Health Aging. 2019;23(6):494-502. doi: 10.1007/s12603-019-1196-8.

    PubMed 31233069
  • Chittrakul J, Siviroj P, Sungkarat S, Sapbamrer R. Multi-System Physical Exercise Intervention for Fall Prevention and Quality of Life in Pre-Frail Older Adults: A Randomized Controlled Trial. Int J Environ Res Public Health. 2020 Apr 29;17(9):3102. doi: 10.3390/ijerph17093102.

    PubMed 32365613
  • Sato R, Vatic M, Peixoto da Fonseca GW, Anker SD, von Haehling S. Biological basis and treatment of frailty and sarcopenia. Cardiovasc Res. 2024 Jul 31;120(9):982-998. doi: 10.1093/cvr/cvae073.

    PubMed 38828887
  • Izquierdo M, Merchant RA, Morley JE, Anker SD, Aprahamian I, Arai H, Aubertin-Leheudre M, Bernabei R, Cadore EL, Cesari M, Chen LK, de Souto Barreto P, Duque G, Ferrucci L, Fielding RA, Garcia-Hermoso A, Gutierrez-Robledo LM, Harridge SDR, Kirk B, Kritchevsky S, Landi F, Lazarus N, Martin FC, Marzetti E, Pahor M, Ramirez-Velez R, Rodriguez-Manas L, Rolland Y, Ruiz JG, Theou O, Villareal DT, Waters DL, Won Won C, Woo J, Vellas B, Fiatarone Singh M. International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines. J Nutr Health Aging. 2021;25(7):824-853. doi: 10.1007/s12603-021-1665-8.

    PubMed 34409961
  • Allison R 2nd, Assadzandi S, Adelman M. Frailty: Evaluation and Management. Am Fam Physician. 2021 Feb 15;103(4):219-226.

    PubMed 33587574
  • Vazquez-Guajardo M, Rivas D, Duque G. Exercise as a Therapeutic Tool in Age-Related Frailty and Cardiovascular Disease: Challenges and Strategies. Can J Cardiol. 2024 Aug;40(8):1458-1467. doi: 10.1016/j.cjca.2024.01.005. Epub 2024 Jan 10.

    PubMed 38215969
  • Yang X, Li S, Xu L, Liu H, Li Y, Song X, Bao J, Liao S, Xi Y, Guo G. Effects of multicomponent exercise on frailty status and physical function in frail older adults: A meta-analysis and systematic review. Exp Gerontol. 2024 Nov;197:112604. doi: 10.1016/j.exger.2024.112604. Epub 2024 Oct 21.

    PubMed 39426607
  • Sadjapong U, Yodkeeree S, Sungkarat S, Siviroj P. Multicomponent Exercise Program Reduces Frailty and Inflammatory Biomarkers and Improves Physical Performance in Community-Dwelling Older Adults: A Randomized Controlled Trial. Int J Environ Res Public Health. 2020 May 26;17(11):3760. doi: 10.3390/ijerph17113760.

    PubMed 32466446
  • Dent E, Daly RM, Hoogendijk EO, Scott D. Exercise to Prevent and Manage Frailty and Fragility Fractures. Curr Osteoporos Rep. 2023 Apr;21(2):205-215. doi: 10.1007/s11914-023-00777-8. Epub 2023 Mar 28.

    PubMed 36976491
  • Angulo J, El Assar M, Alvarez-Bustos A, Rodriguez-Manas L. Physical activity and exercise: Strategies to manage frailty. Redox Biol. 2020 Aug;35:101513. doi: 10.1016/j.redox.2020.101513. Epub 2020 Mar 20.

    PubMed 32234291
  • Lee JE, Chun H, Kim YS, Jung HW, Jang IY, Cha HM, Son KY, Cho B, Kwon IS, Yoon JL. Association between Timed Up and Go Test and Subsequent Functional Dependency. J Korean Med Sci. 2020 Jan 20;35(3):e25. doi: 10.3346/jkms.2020.35.e25.

    PubMed 31950779
  • Choi JY, Park JW, Kim KI, Lee YK, Kim CH. Prediction of 5-Year Survival Rate After Hip Fracture Surgery Using a Comprehensive Geriatric Assessment-Based Frailty Score Model. J Korean Med Sci. 2025 Mar 31;40(12):e40. doi: 10.3346/jkms.2025.40.e40.

    PubMed 40165573
  • Kim KJ, Lee SB, Kim CO. How to Assess Frailty: Role of Comprehensive Geriatric Assessment. J Korean Med Sci. 2020 Jan 20;35(3):e34. doi: 10.3346/jkms.2020.35.e34. No abstract available.

    PubMed 31950780
  • Lee H, Lee E, Jang IY. Frailty and Comprehensive Geriatric Assessment. J Korean Med Sci. 2020 Jan 20;35(3):e16. doi: 10.3346/jkms.2020.35.e16.

    PubMed 31950775

Questions about this trial

What is this clinical trial studying?

An observational study of Frail Elderly and Fall Risk, run by University of Vigo at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Physical Performance Short Physical Performance Battery (SPPB) (time frame: Baseline (T0) and post-intervention (8-12 weeks)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07572851, which also lists 23 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in